Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

Announcement on Cashing of Phase III Ultra-Short-Term Financing Bonds of 2025

· Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange
Announcement on Cashing of Phase III Ultra-Short-Term Financing Bonds of 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment